StockDuty ← Dashboard Aug 26, 2026 03:30 PM ET
CatalystMacro

BRISTOL MYERS REPORTEDLY EXITS CELLARES PACT PROMPTING RESTRUCTURING AT CELL THERAPY MAKER - SEEKINGALPHA

Deal exit signals strategic shift, triggering restructuring risk at cell therapy maker.

What changed
Why it matters
Deal exit signals strategic shift, triggering restructuring risk at cell therapy maker.
Sources
seekingalpha
Related signals
PCE INFLATION GAUGE FALLS FOR THE FIRST TIME SINCE THE PANDEMIC. THE DANGER IS FAR FROM OVER. - MARKETWATCH →OpenAI unveils Rosalind Biodefense program for biodefense, pandemic preparedness — via SEEKINGALPHA →GeoVax Labs, Inc. (GOVX) Discusses Building a Resilient Infectious Disease Preparedness Strategy Focused on Ebola, Marbu →